Wide Ranks

FBLG

FibroBiologics, Inc.

2.56

Top Statistics
Market Cap 88 M Forward PE -9.85 Revenue Growth 0.00 %
Current Ratio 1.23 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -6.67 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 7 M Total Cash Per Share 0.2260 Total Debt 1 M
Total Debt To Equity 57.07 Current Ratio 1.23 Book Value Per Share 0.0810
All Measures
Short Ratio 1273.00 % Message Board Id finmb_1758633149 Shares Short Prior Month 2 M
Return On Equity -2.68 City Houston Uuid 6752a379-a671-33c4-8602-9f32d42c8f6a
Previous Close 2.47 First Trade Date Epoch Utc 1 B Book Value 0.0810
Total Debt 1 M Volume 108392 Price To Book 31.60
Fifty Two Week Low 1.08 Total Cash Per Share 0.2260 Shares Short Previous Month Date 1 B
Target Median Price 12.00 Max Age 86400 Recommendation Mean 1.67
Sand P52 Week Change 0.3133 Target Mean Price 12.75 Net Income To Common -17779000
Short Percent Of Float 0.0888 Implied Shares Outstanding 34 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 180050 Average Volume10days 180050
Total Cash 7 M Next Fiscal Year End 1 B Held Percent Insiders 0.2399
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 2.47 Target Low Price 11.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 2.91 Open 2.46 Free Cashflow -470000
State TX Dividend Yield 0.00 % Return On Assets -0.6577
Time Zone Short Name EST Trailing Eps -0.5500 Day Low 2.46
Address1 455 East Medical Center Boulevard Shares Outstanding 34 M Price Hint 4
Target High Price 16.00 Website https://www.fibrobiologics.com 52 Week Change -0.8537
Average Volume 403735 Forward Eps -0.3600 Recommendation Key buy
Compensation As Of Epoch Date 1 B Quick Ratio 117.20 % Is_sp_500 False
Regular Market Day High 2.69 Profit Margins 0.00 % Debt To Equity 57.07
Fifty Two Week High 46.00 Day High 2.69 Shares Short 2 M
Regular Market Open 2.46 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0730 Operating Cashflow -10429000
Currency USD Time Zone Full Name America/New_York Market Cap 88 M
Is_nasdaq_100 False Zip 77598 Quote Type EQUITY
Industry Biotechnology Long Name FibroBiologics, Inc. Regular Market Day Low 2.46
Held Percent Institutions 0.1586 Current Price 2.56 Address2 Suite 300
Enterprise To Ebitda -6.67 Financial Currency USD Current Ratio 1.23
Industry Disp Biotechnology Number Of Analyst Opinions 4 Country United States
Float Shares 24 M Two Hundred Day Average 6.48 Enterprise Value 82 M
Forward PE -9.85 Regular Market Volume 108392 Ebitda -12364000
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company.

It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials.

It holds 150+ U.

S.

and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer.

FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.